JAMA 4 Jan 2012 Vol 307 37 The gradual makeover of JAMA takes a further step with the introduction of a series of Viewpoints in the opening section. Quite nice, […]
Month: January 2012
Leslie Shanks: False positive HIV tests: the problem no one wants to talk about (and how to solve it)
“Finally, someone is talking about this.” I heard this refrain frequently at the recent International Conference on HIV/AIDS and Sexually Transmitted Infections in Africa (ICASA) in Addis Ababa, Ethiopia, after […]
Research highlights – 6 January 2012
“Research highlights” is a weekly round-up of research papers appearing in the print BMJ. We start off with this week’s research questions, before providing more detail on some individual research […]
Rachel ter Horst on hopeful initial outcomes of combination treatment in patients with HIV and visceral leishmaniasis co-infection
Visceral leishmaniasis (VL), a protozoan disease transmitted by sandflies, is the second biggest parasitic killer worldwide (after malaria). In Ethiopia, the host country for the recent International Conference on HIV/AIDS […]
Mit Philips on the ICASA conference: donor retreat and its consequences for patients and communities
The 2011 International Conference on HIV/AIDS and Sexually Transmitted Infections in Africa (ICASA) conference in Addis Ababa was an experience in contradictions. Presentations about promising new strategies created by scientific breakthroughs, […]
Douglas Noble on the Falconer report
Last year I blogged about the commission set up by Lord Falconer on assisted suicide. It was clear from the outset that this commission was fatally flawed, not least because […]
Stephen Ginn: smartphone health apps for the future
I learnt some interesting facts about mobile phones the other day. For instance, there are 59 countries where mobile phones outnumber people. This refers to mobile phones actually in use, […]
Richard Smith: Does it still make sense for healthcare to be “free” and social care means tested?
Does it make sense for the state to pay tens of thousands of pounds for a drug that might keep a patient with cancer alive for another six weeks and […]
Tom Yates: Separate analysis of independent and industry supported studies would be informative
I am very glad the Cochrane Collaboration exists. However, it is important to consider how its activities might be harmful and to take every effort to mitigate this risk. I […]
David Kerr: 2012, technology and all that
January is the month that heralds the end of procrastination. The New Year is traditionally the time that individuals and organisations look ahead and plan for the future. Among the […]